Literature DB >> 35704146

Could dietary erucic acid lower risk of brain tumors? An epidemiological look to Chinese population with implications for prevention and treatment.

Meric A Altinoz1.   

Abstract

Erucic acid, an omega-9 monounsaturated fatty acid present in Brassicaceae plants (rapeseed and mustard oils) is highly consumed by the Chinese population and according to several global survey studies, its highest levels are encountered in the Chinese women's milk. Erucic acid is an activating ligand of the transcription factor PPARδ and an inhibitor of the transcriptional activity of PPARγ, which drive tumorigenesis of glioblastomas and medulloblastomas. In this theoretical review, we propose that erucic acid in diet may associate with the risk of brain tumors. High grade brain tumors including medulloblastomas in children and glioblastomas in adults have devastating consequences for human health and the latter tumors are practically incurable. CONCORD-3 epidemiological study recently published in 2021 revealed a low ratio of medulloblastomas in the pediatric age group and also a low ratio of glioblastomas in adults in the Chinese population. It is certain that such profound differences can not be attributed to a single genetic factor or a single nurture pattern. It is very likely that multiple hereditary, nutritional and environmental factors are responsible for these lower ratios; yet here we propose that erucic acid may be one of the contributing factors. If future epidemiological studies and animal models show antitumor activity of erucic acid regarding brain neoplasias, it can be utilized as a preventive strategy for populations possessing very high risks to develop brain tumors such as those harbouring hereditary syndromes increasing the vulnerability to develop such malignancies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CONCORD-3 study; Erucic acid; Glial tumors; Glioblastoma; PPARs; Prevention

Year:  2022        PMID: 35704146     DOI: 10.1007/s11011-022-01022-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  23 in total

Review 1.  PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism.

Authors:  Meric A Altinoz; Aysel Ozpinar
Journal:  Int Immunopharmacol       Date:  2019-02-08       Impact factor: 4.932

2.  Breast milk fatty acid composition: a comparative study between Hong Kong and Chongqing Chinese.

Authors:  Z Y Chen; K Y Kwan; K K Tong; W M Ratnayake; H Q Li; S S Leung
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

Review 3.  NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.

Authors:  M A Altinoz; R Korkmaz
Journal:  Neoplasma       Date:  2004       Impact factor: 2.575

4.  Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis.

Authors:  Meric A Altinoz; Ayhan Bilir; İlhan Elmaci
Journal:  Chem Biol Interact       Date:  2018-08-22       Impact factor: 5.192

5.  Relationship between dietary fatty acid, selenium, and degenerative cardiomyopathy.

Authors:  M L Bierenbaum; Y Chen; H Lei; T Watkins
Journal:  Med Hypotheses       Date:  1992-09       Impact factor: 1.538

6.  Uptake and metabolism of plasma-derived erucic acid by rat brain.

Authors:  Mikhail Y Golovko; Eric J Murphy
Journal:  J Lipid Res       Date:  2006-03-08       Impact factor: 5.922

7.  Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma.

Authors:  Bobby Bhatia; Chad R Potts; Cemile Guldal; SunPhil Choi; Andrey Korshunov; Stefan Pfister; Anna M Kenney; Zaher A Nahlé
Journal:  Acta Neuropathol       Date:  2012-03-11       Impact factor: 17.088

8.  The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).

Authors:  Fabio Girardi; Brian Rous; Charles A Stiller; Gemma Gatta; Naomi Fersht; Hans H Storm; Jessica R Rodrigues; Christian Herrmann; Rafael Marcos-Gragera; Rafael Peris-Bonet; Mikhail Valkov; Hannah K Weir; Ryan R Woods; Hui You; Patricia A Cueva; Prithwish De; Veronica Di Carlo; Tom Børge Johannesen; Carlos A Lima; Charles F Lynch; Michel P Coleman; Claudia Allemani
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 13.029

Review 9.  Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas.

Authors:  Giulia Ceglie; Giada Del Baldo; Emanuele Agolini; Martina Rinelli; Antonella Cacchione; Francesca Del Bufalo; Maria Vinci; Roberto Carta; Luigi Boccuto; Evelina Miele; Angela Mastronuzzi; Franco Locatelli; Andrea Carai
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

10.  The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.

Authors:  Xiaoying Ding; Xinsheng Han; Haozheng Yuan; Yong Zhang; Ya Gao
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.